Q2 Earnings Analysis: Zimmer Biomet expects merger to spark growth
This article was originally published in Clinica
Executive Summary
In its first quarterly earnings call since Zimmer and Biomet merged in June, Zimmer Biomet explained its plans for uniting the two orthopaedics companies to accelerate revenue growth, especially in joint replacement products, which are currently stuck in the low single digits.